Log In
Print
BCIQ
Print
Print this Print this
 

SYN120

  Manage Alerts
Collapse Summary General Information
Company Biotie Therapies Corp.
DescriptionOral dual antagonist of the serotonin (5-HT6) receptor and serotonin (5-HT2A) receptor
Molecular Target Serotonin (5-HT6) receptor ; Serotonin (5-HT2A) receptor
Mechanism of ActionSerotonin (5-HT6) receptor antagonist
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today